Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
Youn Huh, Yoon Jeong Cho, Ga Eun Nam
Journal of Obesity & Metabolic Syndrome (2022) Vol. 31, Iss. 1, pp. 17-27
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Wah‐Kheong Chan, Kee Huat Chuah, Ruveena Bhavani Rajaram, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 3, pp. 197-213
Open Access | Times Cited: 274
The Related Metabolic Diseases and Treatments of Obesity
Ming Yang, Shuai Liu, Chunye Zhang
Healthcare (2022) Vol. 10, Iss. 9, pp. 1616-1616
Open Access | Times Cited: 78
2023 Obesity Fact Sheet: Prevalence of Obesity and Abdominal Obesity in Adults, Adolescents, and Children in Korea from 2012 to 2021
Su‐Min Jeong, Jin‐Hyung Jung, Ye Yang, et al.
Journal of Obesity & Metabolic Syndrome (2024) Vol. 33, Iss. 1, pp. 27-35
Open Access | Times Cited: 31
Association between the cardiometabolic index and NAFLD and fibrosis
Laisha Yan, Xiao Hu, Shanshan Wu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Eugene Han, Byung‐Wan Lee, Eun Seok Kang, et al.
Metabolism (2024) Vol. 152, pp. 155789-155789
Closed Access | Times Cited: 18
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 31
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Eugene Han, Kyungdo Han, Yong‐ho Lee, et al.
Diabetes & Metabolism Journal (2023) Vol. 47, Iss. 3, pp. 347-355
Open Access | Times Cited: 25
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
Scott L. Friedman
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 161-169
Open Access | Times Cited: 14
Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together
Rossella Maresca, Irene Mignini, Simone Varca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3278-3278
Open Access | Times Cited: 9
Association of pan-immune-inflammatory value with metabolic dysfunction-associated steatotic liver disease: findings from NHANES 2017–2020
Lian-Zhen Huang, Zi-Wei Ni, Qi Yao, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Soyeon Shin, Jaeyoung Kim, Ju‐Yeun Lee, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 4, pp. 289-302
Open Access | Times Cited: 22
The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population
Eun Kyung Choe, Hae Yeon Kang
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis
Basile Njei, Eri Osta, Nelvis Njei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model
Seung‐Ju Hwang, Yujin Choi, Jing‐Hua Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116250-116250
Open Access | Times Cited: 6
Molecular targets and therapeutic potential of baicalein: a review
Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, et al.
Drug Target Insights (2024) Vol. 18, Iss. 1, pp. 30-46
Open Access | Times Cited: 6
Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery
Marcelo Hatto, Victor Kenzo Ivano, Martinho Antônio Gestic, et al.
Obesity Surgery (2023) Vol. 33, Iss. 5, pp. 1580-1586
Closed Access | Times Cited: 14
The Impact and Burden of Dietary Sugars on the Liver
Helaina Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 14
Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK/autophagy-mediated suppression of ER stress
Sung Woo Choi, Wonjun Cho, Heeseung Oh, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115815-115815
Closed Access | Times Cited: 13
Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis
Dachuan Jin, Shunqin Jin, Tao Zhou, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 5
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights
Ιωάννα Αγγελετοπούλου, Efthymios P. Tsounis, Christos Triantos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4901-4901
Open Access | Times Cited: 5
Leisure-Time Physical Activity in Subjects with Metabolic-Dysfunction-Associated Steatotic Liver Disease: An All-Cause Mortality Study
Ritanna Curci, Caterina Bonfiglio, Isabella Franco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3772-3772
Open Access | Times Cited: 5
Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis
Ester Díez-Sainz, Paula Aranaz, Ez‐Zoubir Amri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1721-1721
Open Access | Times Cited: 4
Association between dairy-rich dietary pattern and metabolic dysfunction-associated steatotic liver disease: Findings from the Korean Genome and Epidemiology Study
Jong Hee Lee, Hye Sun Lee, Soyoung Jeon, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 9, pp. 1529-1536
Closed Access | Times Cited: 4
Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation
Navya Malladi, Devidas Lahamge, Balaji Sanjay Somwanshi, et al.
Cellular Signalling (2024) Vol. 121, pp. 111299-111299
Closed Access | Times Cited: 4
Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Swasthika Gurjar, R. A., Raghavendra Upadhya, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top